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Risk factors for short- and long-term complications after groin
surgery in vulvar cancer
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HP van de Nieuwenhof1 and JA de Hullu1
1Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands;
2Department of Statistics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; 3Department of Obstetrics and Gynaecology,
University Medical Centre Groningen, Groningen, The Netherlands; 4Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen,
The Netherlands
BACKGROUND: The cornerstone of treatment in early-stage squamous cell carcinoma (SCC) of the vulva is surgery, predominantly
consisting of wide local excision with elective uni- or bi-lateral inguinofemoral lymphadenectomy. This strategy is associated with a
good prognosis, but also with impressive treatment-related morbidity. The aim of this study was to determine risk factors for the
short-term (wound breakdown, infection and lymphocele) and long-term (lymphoedema and cellulitis/erysipelas) complications after
groin surgery as part of the treatment of vulvar SCC.
METHODS: Between January 1988 and June 2009, 164 consecutive patients underwent an inguinofemoral lymphadenectomy as part of
their surgical treatment for vulvar SCC at the Department of Gynaecologic Oncology at the Radboud University Nijmegen Medical
Centre. The clinical and histopathological data were retrospectively analysed.
RESULTS: Multivariate analysis showed that older age, diabetes, ‘en bloc’ surgery and higher drain production on the last day of drain
in situ gave a higher risk of developing short-term complications. Younger age and lymphocele gave higher risk of developing long-
term complications. Higher number of lymph nodes dissected seems to protect against developing any long-term complications.
CONCLUSION: Our analysis shows that patient characteristics, extension of surgery and postoperative management influence
short- and/or long-term complications after inguinofemoral lymphadenectomy in vulvar SCC patients. Further research of
postoperative management is necessary to analyse possibilities to decrease the complication rate of inguinofemoral
lymphadenectomy; although the sentinel lymph node procedure appears to be a promising technique, in B50% of the patients
an inguinofemoral lymphadenectomy is still indicated.
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Vulvar squamous cell carcinoma (SCC) is a rare disease and
accounts for B3–5% of all female genital malignancies (Hacker,
2005). The incidence is B1–2 per 100 000 (van de Nieuwenhof
et al, 2009). The majority of the patients with vulvar SCC have
early-stage disease: a cT1 (o2 cm) or cT2 (42 cm) tumour
without suspicious inguinal lymph nodes. The standard treatment
of early-stage SCC of the vulva consists of wide local excision
(WLE) of the tumour combined with an inguinofemoral lympha-
denectomy (removal of all superficial lymph nodes and the medial
femoral lymph nodes) (Levenback et al, 1996; de Hullu et al, 2004).
The inguinofemoral lymphadenectomy has significant short- and
long-term complications, which are a major concern for both
patients and clinicians. Wound breakdown, wound infection,
formation of lymphoceles, development of lymphoedema and
cellulitis/erysipelas are the most documented complications,
occurring in up to 85% of the patients (Podratz et al, 1983;
Gaarenstroom et al, 2003).
Only 25–35% of patients with early-stage disease will have
lymph node metastases (Hacker et al, 1981; Burger et al, 1995; Bell
et al, 2000; Katz et al, 2003). There are no noninvasive techniques
such as palpation, ultrasound, CT, PET and MRI available with a
high enough negative predictive value to safely omit inguinofe-
moral lymphadenectomy in a selection of patients (Oonk et al,
2006). This urged the introduction of the sentinel lymph node
(SLN) procedure in vulvar SCC. After excellent results in different
accuracy studies (Ansink et al, 1999; De Cicco et al, 2000; de Hullu
et al, 2000; Levenback et al, 2001; Sliutz et al, 2002; Moore et al,
2003), van der Zee et al (2008) showed in the ‘Groningen
International Study on Sentinel nodes in Vulvar cancer I’
(GROINSS-V I) with the combined technique that in early-stage
vulvar SCC patients with a negative SLN, the groin recurrence rate
is low, survival is excellent and the treatment-related morbidity is
minimal.
Despite the excellent outcomes of the SLN procedure, only
patients with small (o4 cm) unifocal tumours are eligible for this
technique. Therefore, in B50% of the patients, there is still an
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indication for inguinofemoral lymphadenectomy. The modifica-
tions of the past decades have been introduced to decrease
morbidity without compromising prognosis. ‘En bloc’ surgery has
been replaced by the triple incision technique (de Hullu et al,
2002). Performing a superficial lymphadenectomy alone gives a
decrease in survival (Stehman et al, 1992a; Burke et al, 1995), and
hence at least the lymph nodes medial of the femoral vessels
should be removed. In the literature, sparing of the saphenous vein
does not reduce lymphoedema in all studies (Podratz et al, 1983;
Zhang et al, 2000; Rouzier et al, 2003). Sartorius transposition did
not decrease the morbidity (Rouzier et al, 2003; Judson et al, 2004).
The direct postoperative management for patients with vulvar
SCC has not been described extensively. Gould et al (2001) showed
that prophylactic antibiotics and duration of drains in situ were
no predictors for the development of wound infection and late
complications (lymphoedema and cellulitis). The drains were
removed when the output waso30ml per day. Gaarenstroom et al
(2003) described that the drains were removed when the fluid
production waso50ml per day after at least 5 days. However, the
reason for this specific duration was not based on study results. In
breast cancer, the postoperative management after axillary
lymphadenectomy has been studied in more detail. There is no
clear evidence that the use of a drain after axillary surgery reduces
the incidence of lymphocele formation (Zavotsky et al, 1998;
Talbot and Magarey, 2002; Soon et al, 2005). The studies in breast
cancer that compared early with late drain removal (Inwang et al,
1991; Gupta et al, 2001; Dalberg et al, 2004) concluded that early
drain removal was safe, but that the incidence of lymphoceles was
higher in this group.
The aim of this study is to investigate the influence of patients’
characteristics, extension of surgery and postoperative manage-
ment on the short- and long-term complication rate after




Data of 283 consecutive patients with vulvar SCC who were treated
at the Department of Gynaecologic Oncology at the Radboud
University Nijmegen Medical Centre (RUNMC) between 1 January
1988 and 30 June 2009 were retrieved from medical files. A total of
78 patients were excluded from the current analysis because their
groins were not treated surgically (n¼ 8), the primary treatment
took place in another medical centre (n¼ 21), no groin surgery
was performed at primary treatment (n¼ 36), only superficial
inguinal lymphadenectomy was performed (n¼ 4) only debulking
of lymph node metastases was performed (n¼ 2) or posterior
exenteration was performed (n¼ 3). Four patients were excluded
because their medical files could not be retrieved. In 205 patients
groin surgery was performed; 41 patients only underwent SLN
procedure and were excluded. In 2001, the SLN procedure
(unilateral or bilateral) was introduced in the RUNMC initially
in an accuracy study (followed by lymphadenectomy) that
preceded the GROINSS V-studies by van der Zee et al (2008).
Data of 164 patients were available for further analysis in this
study. Local surgery consisted of a WLE or radical vulvectomy.
From 1988 to 1993, standard local treatment consisted of a radical
vulvectomy. After 1993, the WLE was introduced; it was carried
out when the tumour was clinically resectable with a macro-
scopically measured normal tissue margin of 1–2 cm despite the
tumour diameter. After the introduction of the WLE, radical
vulvectomy was only considered in patients with multifocal
tumours and in case of an abnormal remainder of the vulva with
complaints. Groin surgery consisted of ‘en bloc’ inguinofemoral
lymphadenectomy from 1988 to 1993. In 1993, the triple incision
technique was introduced (de Hullu et al, 2002): when the medial
margin of the tumour was 41 cm from the midline, unilateral or
otherwise a bilateral inguinofemoral lymphadenectomy was
performed. A total of 62% of our patients underwent inguinofe-
moral lymphadenectomy through triple incision technique after
1993 vs 17% before 1993. It took some time until the triple incision
technique was fully integrated in our Gynaecologic Oncology
centre. The inguinofemoral lymphadenectomy contained resection
of superficial lymph nodes as well as deep femoral nodes. For the
resection of inguinal lymph nodes, the fatty tissue beneath the
subcutaneous tissue down to the fascia lata was removed. The
saphenous vein was spared when possible. After splitting the fascia
lata, the fatty tissue medial to the femoral vessels within the
opening of the fossa ovalis was resected to perform femoral
lymphadenectomy. The lateral part of the fascia lata was spared
and no sartorius transposition was performed.
Data
All data were retrospectively collected from a database and the
patient charts. Parameters extracted were: patients’ characteristics
(age, diabetes, peripheral vascular disease, body mass index (BMI)
and continuation of antibiotics), type of surgery (‘en bloc’
approach or triple incision technique, unilateral or bilateral
inguinofemoral lymphadenectomy, the ligation of the saphenous
vein, number of removed lymph nodes, presence or absence of
lymph node metastases and adjuvant radiotherapy) and post-
operative management (drain management). In the RUNMC, all
patients received standard antibiotics during surgery: Cefazoline
1000mg and Metronidazol 500mg; in some individual patients, the
treatment with antibiotics extended for some additional days.
‘Antibiotics’ in our study was defined as the continuation of
antibiotics after surgery. Patients who underwent an inguinofe-
moral lymphadenectomy received high-vacuum Redon drains
(775mmHg (0.9 bar) negative pressure) in the groins post-
operatively. In general, the drains were in situ for 5 days and these
were removed when the production was decreasing and under 50–
100ml per day. ‘Duration of the drains in the groins’ was defined
as the time between operation and the day the drains were
removed. The ‘fluid production’ was measured per day. Prescrip-
tion of elastic stockings was a standard procedure in patients who
underwent inguinofemoral lymphadenectomy. ‘Hospitalisation
time’ was defined as the day of operation (day 0) and the number
of postoperative days in the hospital. The influence of adjuvant
radiotherapy was only assessed for the long-term complications.
Definitions and the frequencies of the short- and long-term
complications after inguinofemoral lymphadenectomy are shown
in Table 1. In total, 137 patients (84%) suffered from a
complication of any kind after inguinofemoral lymphadenectomy.
We also assessed the frequency of any of the short-term
complications and any of the long-term complications. Standard
follow-up was every 3 months in the first 2 years; from the third to
the fifth year, it was twice a year and yearly thereafter.
Statistical methods
All events were described per groin, but analysis of complication
rate per groin might overrate the influence of patient character-
istics, because these were doubled in case of a bilateral
lymphadenectomy. In patients who underwent bilateral lympha-
denectomy, we randomly analysed the right or the left groin in
order to minimise bias. We started at the top of the database and
took the right groin in the first patient and the left groin in the
second and so on without knowing in which groin the complica-
tions occurred.
Variables eligible for entry were analysed using SPSS software
(version 16.0.01 for Windows, SPSS, Chicago, IL, USA). Univariate
logistic regression was used to assess the risk of patients’
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characteristics, type of surgery and postoperative management on
the short-term complications and long-term complications,
respectively any of the short-term complications and the long-
term complications as the single type complications. The odds
ratios with the 95% confidence interval (CI) are presented.
Multivariate logistic regression with forward selection procedure
was used to identify those variables that independently contributed
to the risk of short-term complications and long-term complica-
tions (statistically significant variables from univariate logistic
regression). After entry the adjusted odds ratios with 95% CI of the
final model are presented. A P-value of o0.05 was considered
statistically significant.
An IRB approval was not necessary for this retrospective study.
RESULTS
Of all patients who underwent inguinofemoral lymphadenectomy
for primary SCC of the vulva (n¼ 164), 140 patients underwent
primary inguinofemoral lymphadenectomy, whereas 24 patients
underwent inguinofemoral lymphadenectomy subsequent to SLN
procedure during the learning curve (with standard inguinofemoral
lymphadenectomy after SLN procedure) or because of positive
SLN(s) in GROINSS-V I (van der Zee et al, 2008). In 301 groins of
164 patients, an inguinofemoral lymphadenectomy was performed
(27 patients only unilateral), of which 73 patients underwent
surgery through the ‘en bloc’ approach. Figure 1 shows a flowchart
of patients with SCC who underwent groin surgery. Table 2 shows
the features of the research population.
The SLN procedure was not yet introduced in our department
before 2001. In retrospect, B50% of the patients in our study
population were not or would not have been eligible for a SLN
procedure because the tumour was 44 cm and/or multifocal. The
details of use (duration and results) of the stockings were not well
documented in the medical charts, and hence this item was
excluded from the analysis.
Risk factors for short-term complications and long-term
complications were assessed with univariate analysis (Tables 3
and 4).
Using multivariate analysis, ‘en bloc’ surgery (odds ratio 2.72,
95% CI 1.16–6.37) and older age (odds ratio 1.06, 95% CI 1.02–
1.10) were both independent risk factors for developing wound
breakdown. ‘En bloc’ surgery (odds 2.66, 95% CI 1.15–6.15)
and higher drain production on the last day the drain was in situ
Table 1 Overview of short- and long-term complications of the groin after inguinofemoral lymphadenectomy (N¼ 164)
n/N (%)
Short term (o4 weeks)
Wound breakdown 30/160 (18.8) Disrupted groin wound(s) 42 cm
Wound infection 46/161 (28.6) Purulent exudates and/or positive culture and erythema, oedema and localised pain
Lymphocele 47/161 (29.2) Clinically obvious and/or confirmed by puncture or ultrasound scan
Any short-term complication 94/161 (57.3) One or more of the three short-term complications
Long term (44 weeks)
Lymphoedema 78/160 (48.8) Elastic bandages or other forms of lymph drainage were required
Cellulitis/erysipelas 54/160 (33.8) Erythematous and scalding skin with/without positive culture for Streptococcus and T 439 1C
Any long-term complication 102/160 (63.8) One or more of the two long-term complications
Abbreviations: N¼ patients with valid observation; n¼ number of patients with a complication.
Number of patients
(N =283)
Included patients (N =205)
SLN procedure (N =41)
Local surgery
Wide local excision (N =94)
Radical vulvectomy (N =111)
Excluded patients: 75
No surgical treatment (N =8)
Stage IA (N =16)
Patients refused groin surgery/co-morbidity (N =20)
Primary treatment in another hospital (N =21)
Superficial inguinal lymphadenectomy (N =4)
Debulking of lymph node metastases (N =2)
Medical files not retrieved (N =4)
Exenteration posterior (N =3)
Groin surgery (N =205)
Inguinofemoral lymphadenectomy (N =164)
Primary: 140
Subsequent to SLN procedure: 24
Figure 1 Inclusion chart.
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(odds ratio 1.05, 95% CI 1.00–1.09) were the only independent risk
factors for wound infection. Higher drain production on the last
day the drain was in situ (odds ratio 1.05, 95% CI 1.01–1.10) was a
risk factor for developing lymphocele. Diabetes (odds ratio 4.10,
95% CI 1.04–16.05) and higher drain production on the last day
the drain was in situ (odds ratio 1.11, 95% CI 1.04–1.19) were risk
factors for developing any of the short-term complications.
Younger age was the only independent risk factor for developing
lymphoedema (odds ratio 0.95, 95% CI 0.93–0.98). The indepen-
dent risk factors for cellulitis/erysipelas were younger age (odds
ratio 0.96, 95% CI 0.93–0.98) and lymphocele (odds ratio 3.28,
95% CI 1.50–7.19). Higher number of lymph nodes dissected
seems to protect against developing any long-term complications
(odds ratio 0.92, 95% CI 0.84–1.00) and younger age was a risk
factor (odds ratio 0.94, 95% CI 0.92–0.97; Table 5).
DISCUSSION
In this study we found different risk factors for the short- and
long-term complications after inguinofemoral lymphadenectomy
as part of the standard treatment for primary vulvar SCC. Older
age, diabetes, ‘en bloc’ surgery and higher drain production on the
last day the drain was in situ were significant risk factors for short-
term complications. Younger age and lymphocele gave higher risk
of developing long-term complications.
We found that older age was associated with higher risk for
wound breakdown. This can be explained by the deterioration of
wound healing with age. On the other hand, younger age was
correlated with the long-term complications lymphoedema and
cellulitis/erysipelas. One should realise that younger women are
more active and might be more limited in their daily activities by
possible lymphoedema; older people may experience more
restrictions from other diseases, such as cardiac problems
resulting in lymphoedema. Our study showed that diabetes was
associated with wound breakdown and any short-term complica-
tion. It is well known that diabetes mellitus is associated with
wound healing problems in many surgical disciplines (Trussell
et al, 2008; Chen et al, 2009; McConnell et al, 2009; Ogihara et al,
2009). Therefore, the glucose levels in patients with diabetes
should be regulated strictly to diminish the influence of diabetes
on the short-term complications.
In our study the ‘en bloc’ approach was the only surgical
technique-related risk factor found. In 1993, the triple incision
technique was introduced in the RUNMC. In our study we found a
decrease in complication rate after 1993, especially in the short-
term complication rate (76.2% before 1993 and 55.7% after 1993).
We did expect to find this result, as our study showed, as expected
in literature (Hacker et al, 1981; Podratz et al, 1983; Lin et al,
1992), the ‘en bloc’ approach to be a risk factor for both wound
breakdown and wound infection. This can also be explained by the
higher rate of triple incisions performed after 1993 compared with
before 1993 (61.7% vs 17.4%). Nowadays, ‘en bloc’ surgery is only
performed in patients with large suspicious inguinofemoral lymph
nodes to prevent skin bridge and groin recurrences. We
hypothesised that a higher total amount of dissected lymph nodes
during surgery would impose a risk for lymphoedema, which was
based on the idea that less lymph nodes may drain less lymph
fluid. The mean number of nodes dissected in our study was 9.45
nodes per groin, and a higher amount of nodes dissected as a risk
factor for lymphoedema was not confirmed in this study. On the
contrary, a higher amount seemed to protect against developing
any long-term complications. Besides, only in cellulitis/erysipelas a
cutoff point was recognised, namely 10 lymph nodes (410 lymph
nodes dissected posed protection). We did not have an explanation
for this finding. Courtney-Brooks et al (2010) showed that removal
of 410 lymph nodes might be associated with better survival in
FIGO stage III patients. The prognostic impact of the number of
lymph nodes dissected remains unclear. It is advised to remove
between 6 and 8 lymph nodes per groin (Butler et al, 2010;
Woelber et al, 2011), but variations in anatomy and other factors
make node counting an unreliable measure of surgical quality
(Stehman et al, 2009).
In melanoma of the lower extremities, patients also undergo
lymphadenectomy, in most cases combined with pelvic lympha-
denectomy. There are comparable complication rates described as
in vulvar cancer patients: wound breakdown 3–26%, wound
infection 9–30%, lymphocele 5–46% and lymphoedema 20–64%
(Baas et al, 1992; Beitsch and Balch, 1992; Karakousis and Driscoll,
1994; Lawton et al, 2002; Serpell et al, 2003; de Vries et al, 2006).
Apparently, morbidity after inguinofemoral lymphadenectomy is
impressive despite the type of the primary tumour.
The use of drains after inguinofemoral lymphadenectomy is
generally accepted worldwide and therefore used in our gynaeco-
logic oncology department. There are no standardised protocols
for the duration of drainage, but in most cases the drains are left in
situ for at least 5 days; the postoperative management at the
RUNMC is to remove the drains when the production has
decreased under 50–100ml per day. Only two retrospective
studies on postoperative management in vulvar SCC report a
postoperative protocol on drain management; either remove the
drain when the output was o30ml per day or when the fluid
production was o50ml per day after at least 5 days (Gould et al,
2001; Gaarenstroom et al, 2003). Both studies showed, in
accordance with our results, that duration of the drain in situ
had no influence on the short- and long-term complications after
Table 2 Features of the research population with median values and
percentages
Variables N Median (range) n (%)
Patient characteristics
Age (years) 164 71 (31–92) —
Diabetes 164 — 19 (11.6)
Peripheral vascular disease 164 — 8 (4.9)
BMI (kgm–2) 155 26.6 (17.6–48.4) —
Continuation of antibiotics 162 — 99 (61.1)
Surgical technique
Bilateral IFL 164 — 137 (83.5)
En bloc 164 — 73 (44.5)
Ligation saphenous vein 160 — 32 (20.0)
Total nodes dissected (no. of nodes) 164 9 (0–25) —
Total positive nodes (no. of nodes) 164 0 (0–7) —
Extracapsular growth (no. of nodes) 164 0 (0–7) —
Postoperative management
Duration drain (days) 149 8 (0–27) —
Drain production last day (ml) 122 40.0 (0–860) —
Total drain production (ml) 145 630 (20–7540) —
Adjuvant radiotherapy 163 — 40 (24.5)
Hospital stay (days) 164 15 (4–60) —
Follow-up (months) 164 50.3 (0.1–215) —









Abbreviations: BMI¼ body mass index; FIGO¼ International Federation of Gynae-
cology and Obstetrics; N¼ number of patients with valid observation; n¼ number of
patients with specific feature; IFL¼ inguinofemoral lymphadenectomy; — ¼ not
applicable.
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inguinofemoral lymphadenectomy. There is limited literature on
drain management in patients after inguinofemoral lymphade-
nectomy for vulvar SCC, probably because of the low incidence of
vulvar SCC and/or the focus on improving quality of life by the
SLN procedure.
In contrast with the groin, drain management in the axilla after
breast cancer treatment has been extensively studied; most
surgeons remove the drain when the drainage volume is o20–
50ml in the preceding 24 h and this may take up to 10 days
(Tadych and Donegan, 1987; Yii et al, 1995; Bundred et al, 1998;
Kopelman et al, 1999; Woodworth et al, 2000). Barwell et al (1997)
showed that patients who developed a lymphocele after breast
cancer surgery had a higher mean total drain volume (480ml) than
patients who did not develop a lymphocele (240ml). We found that
the total volume of fluid drained from the groin was B1.5 times
higher, without a significant difference between the patients who
did and did not develop a lymphocele. An explanation may be that
the lymph nodes of the groin have to drain more lymph fluid from
the lower extremities than the lymph nodes in the axilla from the
upper extremities.
Our study showed that a higher drain production on the last day
that the drain was in situ was associated with an increased risk for
lymphocele formation. An explanation for this result is that after
removal of the drain, stasis of lymph fluid takes place, which gives
rise to lymphoceles. Our study is limited by a small group of
patients with known drain production on the last day. These
results confirm our hypothesis that more the fluid drained on the
last day, the higher the incidence of lymphoceles would be as
shown in the studies on breast cancer. In the literature on breast
cancer surgery, the amount of postoperative fluid drainage has
been found to be significantly influenced by the degree of negative
pressure in the drain. The hypothesis is that a high negative
suction pressure in the drain may prevent the leaking lymphatics
and blood vessels from sealing off, thus leading to prolonged
drainage (van Heurn and Brink, 1995; Kopelman et al, 1999; O’Hea
et al, 1999; Chintamani et al, 2005). In vulvar SCC, high-vacuum
drains are used, but none of the studies defined the amount of
negative pressure applied in the drains. There is one prospective
study that compared two types of drains, the Blake and the
Jackson-Pratt drain. This study showed an increased incidence of
overall complication rate associated with the Blake drain (Carlson
et al, 2008). These findings show that there is a need for further
studies to investigate drain management after inguinofemoral
lymphadenectomy.
Compared with a full lymphadenectomy, the SLN procedure has
been shown to significantly reduce postoperative morbidity in the
GROINSS-V I study (van der Zee et al, 2008). Our data revealed a
number of patients who are not eligible for the SLN procedure
because of the size of the tumour or multifocality. These patients
would still require an inguinofemoral lymphadenectomy with the
associated morbidity. Despite the application of the SLN
procedure, the complication rate remains high compared with
Table 3 Odds ratios with 95% confidence interval of patient characteristics, surgery and postoperative management variables for short-term
complications using univariate logistic regression
Wound breakdown Wound infection Lymphocele Any short-term complication
Variables N OR (95% CI) N OR (95% CI) N OR (95% CI) N OR (95% CI)
Age (years) 160 1.06 (1.02–1.10)* 161 1.01 (0.98–1.03) 161 1.01 (0.99–1.04) 160 1.03 (1.01–1.06)*
Diabetes
Yes 19 2.99 (1.07–8.14)* 19 1.99 (0.74–5.32) 19 0.85 (0.29–2.51) 19 4.31 (1.20–5.45)*
No 141 1.00 (Ref) 142 1.00 (Ref) 142 1.00 (Ref) 141 1.00 (Ref)
Peripheral vascular disease
Yes 8 2.78 (0.63–12.33) 8 1.54 (0.35–6.70) 8 2.56 (0.61–10.69) 8 1.24 (0.00– )
No 152 1.00 (Ref) 153 1.00 (Ref) 153 1.00 (Ref) 152 1.00 (Ref)
BMI (in kgm– 2) 153 1.04 (0.96–1.13) 153 1.05 (0.98–1.13) 153 0.96 (0.89–1.04) 153 1.07 (1.00–1.15)
Continuation of antibiotics
Yes 97 1.98 (0.82–4.78) 97 1.13 (0.56–2.29) 97 0.46 (0.23–0.93)* 96 0.66 (0.35–1.28)
No 62 1.00 (Ref) 62 1.00 (Ref) 62 1.00 (Ref) 62 1.00 (Ref)
Bilateral IFL
Yes 134 1.94 (0.54–6.92) 134 0.76 (0.32–1.85) 134 1.54 (0.58–4.11) 134 1.15 (0.50–2.64)
No 26 1.00 (Ref) 27 1.00 (Ref) 27 1.00 (Ref) 27 1.00 (Ref)
En bloc surgery
Yes 71 2.59 (1.14–5.89)* 71 2.61 (1.29–5.26)* 71 0.42 (0.21–0.88)* 71 1.27 (0.67–2.40)
No 89 1.00 (Ref) 90 1.00 (Ref) 90 1.00 (Ref) 89 1.00 (Ref)
Ligation saphenous vein
Yes 30 1.84 (0.72–4.68) 30 0.85 (0.35–2.08) 30 1.04 (0.44–2.49) 30 1.53 (0.66–3.53)
No 127 1.00 (Ref) 127 1.00 (Ref) 127 1.00 (Ref) 127 1.00 (Ref)
Total nodes dissected (number) 160 0.98 (0.89–1.07) 161 0.97 (0.89–1.05) 161 1.03 (0.95–1.11) 161 1.01 (0.94–1.08)
Total positive nodes (number) 160 0.63 (0.35–1.15) 161 1.07 (0.78–1.48) 161 0.97 (0.69–1.36) 161 0.91 (0.67–1.23)
Extracapsular growth (number) 160 0.67 (0.27–1.62) 161 1.20 (0.84–1.73) 161 0.96 (0.63–1.44) 161 0.93 (0.65–1.33)
Duration drain in situ (days) 148 0.99 (0.89–1.09) 148 1.04 (0.96–1.12) 148 1.02 (0.94–1.11) 148 1.01 (0.93–1.08)
Drain production last day (10ml) 121 1.01 (0.97–1.05) 121 1.04 (1.00–1.08)* 121 1.05 (1.01–1.09)* 121 1.11 (1.04–1.19)*
Total drain production (10ml) 145 1.00 (1.00–1.00) 145 1.00 (1.00–1.01) 145 1.00 (1.00–1.01) 145 1.00 (1.00–1.01)*
Abbreviations: N¼ patients with valid observation; OR¼ odds ratio; CI¼ confidence interval; IFL¼ inguinofemoral lymphadenectomy; (10ml)¼ odds ratio assessed per 10ml
increase of lymph fluid; Ref¼ reference; BMI¼ body mass index. *Po0.05.
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the rates described in the literature (Table 6). This may be
explained by the different definitions for complications used in
the literature. Apparently, it is difficult to prevent short- and
long-term complications other than omitting lymphadenectomy.
In the past years, different methods such as ligation of VSM
(Podratz et al, 1983; Zhang et al, 2000; Rouzier et al, 2003),
sartorius muscle transposition (Rouzier et al, 2003; Judson et al,
2004) and sealing with VH fibrin sealant (Carlson et al, 2008) have
been adopted with the attempt to decrease the complication rate,
but none of these methods decreased the complication rate after
inguinofemoral lymphadenectomy. Hopefully, GROINSS-V II will
show that radiotherapy is an attractive and safe alternative for
inguinofemoral lymphadenectomy in a substantial number of
patients with a positive SLN. A few other treatment options have
been described in the literature on vulvar cancer. Primary
radiotherapy could be able to replace inguinofemoral lymphade-
nectomy in patients without suspicious groins. Three studies
showed that primary radiotherapy to the groin results in less
morbidity but also in a higher number of groin recurrences
compared with surgery (Stehman et al, 1992b; Manavi et al, 1997;
Perez et al, 1998). It has been suggested to remove only the bulky
lymph nodes before radiotherapy. A study by Hyde et al (2007)
showed that the survival is not compromised by only resecting the
bulky nodes; however, because of the small study group retro-
spective nature of the study, a randomised prospective study is
recommended. Primary neoadjuvant chemoradiation may be an
option in patients with nonresectable tumours to reduce tumour
volume, achieve resectability and reduce the extent of surgery.
However operability was achieved in 63–92% of cases, surgical
interventions after chemoradiation are associated with high
postoperative morbidity (van Doorn et al, 2006). Chemotherapy
as a single treatment modality is not common. The data available
for any of the applied chemotherapeutic regimens are not
sufficient to recommend routine application (Wagenaar et al,
2001; Cormio et al, 2009; Witteveen et al, 2009). Only primary
radiotherapy decreases the postoperative morbidity, but with
compromising the prognosis. We should keep in mind that a groin
recurrence is nearly always fatal. Hence, we recommend treating all
patients with vulvar cancer optimally; WLE and groin surgery
unless patients are unfit to undergo surgery. Furthermore, research
Table 4 Odds ratios with 95% confidence interval of patient characteristics, surgery and postoperative management variables for long-term complications
using univariate logistic regression
Lymphoedema Cellulitis/erysipelas Any long-term complication
Variables N OR (95% CI) N OR (95% CI) N OR (95% CI)
Age (years) 160 0.95 (0.93–0.98)* 160 0.96 (0.94–0.99)* 160 0.94 (0.92–0.97)*
BMI (in kgm– 2) 152 1.02 (0.95–1.09) 152 1.04 (0.97–1.11) 152 1.04 (0.97–1.12)
Bilateral IFL
Yes 133 1.78 (0.76–4.17) 133 0.84 (0.36–1.99) 133 1.04 (0.44–2.46)
No 27 1.00 (Ref) 27 1.00 (Ref) 27 1.00 (Ref)
En bloc surgery
Yes 70 1.09 (0.59–2.04) 70 0.93 (0.48–1.81) 70 0.75 (0.39–1.44)
No 90 1.00 (Ref) 90 1.00 (Ref) 90 1.00 (Ref)
Ligation saphenous vein
Yes 30 1.58 (0.71–3.53) 30 1.12 (0.49–2.56) 30 1.49 (0.63–3.51)
No 126 1.00 (Ref) 126 1.00 (Ref) 126 1.00 (Ref)
Total nodes dissected (number) 160 0.95 (0.88–1.02) 160 0.94 (0.87–1.02) 160 0.92 (0.85–0.99)*
Total positive nodes (number) 160 1.09 (0.80–1.49) 160 0.86 (0.61–1.23) 160 0.91 (0.67–1.24)
Extracapsular growth (number) 160 0.95 (0.66–1.36) 160 0.74 (0.42–1.30) 160 0.87 (0.60–1.24)
Duration drain in situ (days) 147 1.00 (0.93–1.07) 147 0.93 (0.85–1.01) 147 0.97 (0.90–1.05)
Drain production last day (10ml) 120 1.00 (0.96–1.03) 120 1.02 (0.99–1.06) 120 1.01 (0.97–1.05)
Total drain production (10ml) 144 1.00 (1.00–1.00) 144 1.00 (1.00–1.00) 144 1.00 (1.00–1.00)
Adjuvant radiotherapy
Yes 39 1.02 (0.49–2.09) 39 1.80 (0.86–3.79) 39 1.40 (0.65–3.03)
No 120 1.00 (Ref) 120 1.00 (Ref) 120 1.00 (Ref)
Wound breakdown
Yes 30 0.92 (0.41–2.03) 30 0.53 (0.21–1.33) 30 0.70 (0.31–1.57)
No 129 1.00 (Ref) 129 1.00 (Ref) 129 1.00 (Ref)
Wound infection
Yes 46 0.84 (0.42–1.67) 49 0.93 (0.45–1.93) 49 0.96 (0.47–1.95)
No 114 1.00 (Ref) 114 1.00 (Ref) 114 1.00 (Ref)
Lymphocele
Yes 47 0.62 (0.31–1.24) 47 2.54 (1.25–5.13)* 47 1.01 (0.50–2.04)
No 113 1.00 (Ref) 113 1.00 (Ref) 113 1.00 (Ref)
Any short-term complication
Yes 94 0.67 (0.36–1.27) 94 1.66 (0.84–3.28) 94 0.90 (0.47–1.74)
No 65 1.00 (Ref) 65 1.00 (Ref) 65 1.00 (Ref)
Abbreviations: N¼ patients with valid observation; OR¼ odds ratio; CI¼ confidence interval; BMI¼ body mass index; IFL¼ inguinofemoral lymphadenectomy; (10ml)¼ odds
ratio assessed per 10ml increase of lymph fluid; Ref¼ reference. *Po0.05.
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should focus on development of tailor-made postoperative therapy
such as appropriate postoperative drain management and possibly
lymph drainage therapy for the individual patient who still needs
the inguinofemoral lymphadenectomy to survive vulvar SCC.
In conclusion, age, diabetes, ‘en bloc’ surgery and higher drain
production on the last day the drain was in situ are risk factors for
the development of short- and long-term complications. The
postoperative drain management is the only factor that urges us to
further studies to find the optimal postoperative protocol.
Considering the rarity of SCC of the vulva, this study should
preferably be a randomised multicentre study in patients who
undergo standardised bilateral inguinofemoral lymphadenectomy.
Two different policies with respect to postoperative management
may be studied in both groins of the same patient to exclude bias
by patient-related factors.
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